Home » Topics » BioWorld Science

BioWorld Science
RSS

Yamanouchi claims antidiabetic agents

May 17, 1996

RenaGel results announced at Harvard seminar

May 17, 1996

Zaprinast claimed for treatment of renal failure

May 17, 1996

Schering-Plough adenosine A1 receptor ligand described for renal failure

May 17, 1996

Disappointing results attained in Recordati/SKB BPH trial

May 17, 1996

NovoSeven Spanish introduction imminent

May 17, 1996

Hokuriku TxA2 antagonist selected for evaluation

May 17, 1996

SKB discloses fibrinogen and vitronectin antagonists in patent literature

May 17, 1996

Fibrinogen antagonist from natrual source reported by Takeda

May 17, 1996

Argatroban enters phase III for HIT, HITTS

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...